{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:37:35Z","timestamp":1792427855122,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010032","name":"Health and Family Planning Commission of Sichuan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010032","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychosomatic Research"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jpsychores.2020.109975","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T13:29:27Z","timestamp":1582291767000},"page":"109975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Differences in cytokines between patients with generalised anxiety disorder and panic disorder"],"prefix":"10.1016","volume":"133","author":[{"given":"Zhili","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjiao","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jpsychores.2020.109975_bb0005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/mpr.1359","article-title":"Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States","volume":"21","author":"Kessler","year":"2012","journal-title":"Int. J. Methods Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.jpsychores.2020.109975_bb0010","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1017\/S0033291703001399","article-title":"Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS)","volume":"34","author":"Jacobi","year":"2004","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.jpsychores.2020.109975_bb0015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/NMD.0b013e31827ab1f6","article-title":"Panic attacks in generalized anxiety disorder","volume":"201","author":"Van Ameringen","year":"2013","journal-title":"J. Nerv. Ment. Dis."},{"issue":"2","key":"10.1016\/j.jpsychores.2020.109975_bb0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.31887\/DCNS.2017.19.2\/kdomschke","article-title":"Genetics of generalized anxiety disorder and related traits","volume":"19","author":"Gottschalk","year":"2017","journal-title":"Dialogues Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.jpsychores.2020.109975_bb0025","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/jmg.2010.086876","article-title":"The genetics of panic disorder","volume":"48","author":"Schumacher","year":"2011","journal-title":"J. Med. Genet."},{"issue":"1","key":"10.1016\/j.jpsychores.2020.109975_bb0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1440-1819.2005.01336.x","article-title":"Event-related potentials in panic disorder and generalized anxiety disorder","volume":"59","author":"Hanatani","year":"2005","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.jpsychores.2020.109975_bb0035","first-page":"11","article-title":"Psychophysiological characteristics of panic disorder and generalized anxiety disorder","volume":"113","author":"Gordeev","year":"2013","journal-title":"Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova."},{"issue":"4","key":"10.1016\/j.jpsychores.2020.109975_bb0040","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/hbm.23113","article-title":"Differential alterations of resting-state functional connectivity in generalized anxiety disorder and panic disorder","volume":"37","author":"Cui","year":"2016","journal-title":"Hum. Brain Mapp."},{"issue":"3","key":"10.1016\/j.jpsychores.2020.109975_bb0045","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jad.2012.09.024","article-title":"Decreased hypothalamus volumes in generalized anxiety disorder but not in panic disorder","volume":"146","author":"Terlevic","year":"2013","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.jpsychores.2020.109975_bb0050","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychores.2020.109975_bb0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/pcn.12794","article-title":"Plasma levels of IL-1Ra are associated with schizophrenia","volume":"73","author":"Zhou","year":"2019","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jpsychores.2020.109975_bb0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.psychres.2016.07.027","article-title":"Altered serum levels of TNF-alpha, IL-6 and IL-18 in manic, depressive, mixed state of bipolar disorder patients","volume":"244","author":"Luo","year":"2016","journal-title":"Psychiatry Res."},{"issue":"12","key":"10.1016\/j.jpsychores.2020.109975_bb0065","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatry."},{"key":"10.1016\/j.jpsychores.2020.109975_bb0070","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.comppsych.2019.01.003","article-title":"Changes in serum TNF-alpha, IL-18, and IL-6 concentrations in patients with chronic schizophrenia at admission and at discharge","volume":"90","author":"Luo","year":"2019","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jpsychores.2020.109975_bb0075","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.schres.2018.07.019","article-title":"Cytokines in cerebrospinal fluid of patients with schizophrenia spectrum disorders: New data and an updated meta-analysis","volume":"202","author":"Gallego","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychores.2020.109975_bb0080","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jad.2017.08.082","article-title":"Peripheral proinflammatory cytokines in Chinese patients with generalised anxiety disorder","volume":"225","author":"Tang","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychores.2020.109975_bb0085","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbi.2017.01.021","article-title":"Peripheral inflammatory cytokines and immune balance in generalised anxiety disorder: Case-controlled study","volume":"62","author":"Hou","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jpsychores.2020.109975_bb0090","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ynstr.2016.02.003","article-title":"Association between serum C-reactive protein and DSM-IV generalized anxiety disorder in adolescence: Findings from the ALSPAC cohort","volume":"4","author":"Khandaker","year":"2016","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.jpsychores.2020.109975_bb0095","article-title":"Systematic review and meta-analysis of the association between peripheral inflammatory cytokines and generalised anxiety disorder","volume":"7","author":"Costello","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jpsychores.2020.109975_bb0100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2017.11.094","article-title":"Cytokine alterations in panic disorder: A systematic review","volume":"228","author":"Quagliato","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychores.2020.109975_bb0105","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.pnpbp.2017.10.015","article-title":"Neural and neuroendocrine predictors of pharmacological treatment response in adolescents with depression: A preliminary study","volume":"81","author":"Klimes-Dougan","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychores.2020.109975_bb0110","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1744-9081-10-36","article-title":"Right and left amygdalae activation in patients with major depression receiving antidepressant treatment, as revealed by fMRI","volume":"10","author":"Chen","year":"2014","journal-title":"Behav. Brain Funct."},{"issue":"12","key":"10.1016\/j.jpsychores.2020.109975_bb0115","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1177\/0269881109106899","article-title":"Predictive factors for responding to sertraline treatment: Views from plasma catecholamine metabolites and serotonin transporter polymorphism","volume":"24","author":"Umene-Nakano","year":"2010","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.jpsychores.2020.109975_bb0120","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1177\/0300060514533524","article-title":"Resting-state brain activation correlates with short-time antidepressant treatment outcome in drug-naive patients with major depressive disorder","volume":"42","author":"Wang","year":"2014","journal-title":"J. Int. Med. Res."},{"issue":"2","key":"10.1016\/j.jpsychores.2020.109975_bb0125","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pnpbp.2004.11.003","article-title":"Cytokines and major depression","volume":"29","author":"Schiepers","year":"2005","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.jpsychores.2020.109975_bb0130","first-page":"4195","article-title":"Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder","volume":"55","author":"Kohler","year":"2018","journal-title":"Syst. Rev. Meta-Anal."},{"issue":"5","key":"10.1016\/j.jpsychores.2020.109975_bb0135","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/hup.2333","article-title":"Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder","volume":"28","author":"Yoshimura","year":"2013","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jpsychores.2020.109975_bb0140","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) (Clinical Version)","author":"First","year":"1997"},{"issue":"11","key":"10.1016\/j.jpsychores.2020.109975_bb0145","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1176\/ajp.154.11.1571","article-title":"Multicenter collaborative panic disorder severity scale","volume":"154","author":"Shear","year":"1997","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychores.2020.109975_bb0150","first-page":"285","article-title":"Panic disorder severity scale-chinese version: reliability and validity","volume":"45","author":"Xiong","year":"2012","journal-title":"Chin. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychores.2020.109975_bb0155","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Med. Psychol."},{"key":"10.1016\/j.jpsychores.2020.109975_bb0160","first-page":"342","article-title":"Application of Hamilton anxiety scale in neurosis","volume":"19","author":"Lin","year":"1986","journal-title":"Chin. J. Psychiatry."},{"issue":"10","key":"10.1016\/j.jpsychores.2020.109975_bb0165","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/da.20532","article-title":"Evidence-based guidelines for interpretation of the panic disorder severity scale","volume":"26","author":"Furukawa","year":"2009","journal-title":"Depress. Anxiety."},{"issue":"1\u20132","key":"10.1016\/j.jpsychores.2020.109975_bb0170","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jneuroim.2011.06.009","article-title":"Dopamine up-regulates Th17 phenotype from individuals with generalized anxiety disorder","volume":"238","author":"Ferreira","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.jpsychores.2020.109975_bb0175","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pharep.2014.08.006","article-title":"The MCP-1, CCL-5 and SDF-1 chemokines as pro-inflammatory markers in generalized anxiety disorder and personality disorders","volume":"67","author":"Oglodek","year":"2015","journal-title":"Pharmacol. Rep."},{"issue":"5","key":"10.1016\/j.jpsychores.2020.109975_bb0180","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/da.20564","article-title":"Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder","volume":"26","author":"Hoge","year":"2009","journal-title":"Depress. Anxiety."},{"issue":"2","key":"10.1016\/j.jpsychores.2020.109975_bb0185","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/PSY.0000000000000384","article-title":"Cytokine levels in panic disorder: Evidence for a dose-response relationship","volume":"79","author":"Belem da Silva","year":"2017","journal-title":"Psychosom. Med."},{"issue":"4","key":"10.1016\/j.jpsychores.2020.109975_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hup.2588","article-title":"Altered serum levels of TNF-alpha, IL-6, and IL-18 in depressive disorder patients","volume":"32","author":"Fan","year":"2017","journal-title":"Hum. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.jpsychores.2020.109975_bb0195","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0022-3565(24)29264-8","article-title":"Nucleoside phosphonate interactions with multiple organic anion transporters in renal proximal tubule","volume":"299","author":"Miller","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jpsychores.2020.109975_bb0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-0-585-37970-8_7","article-title":"Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression","volume":"461","author":"Miller","year":"1999","journal-title":"Adv. Exp. Med. Biol"},{"key":"10.1016\/j.jpsychores.2020.109975_bb0205","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pnpbp.2015.06.008","article-title":"The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression","volume":"64","author":"Kim","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychores.2020.109975_bb0210","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1749-6632.2000.tb05426.x","article-title":"Cytokine activation of the HPA axis","volume":"917","author":"Dunn","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.jpsychores.2020.109975_bb0215","first-page":"S445","article-title":"Cortisol as an indicator of hypothalmic-pitituary-adrenal axis dysregulation in patients with panic disorder: A literature review","volume":"27","author":"Jakuszkowiak-Wojten","year":"2015","journal-title":"Psychiatr. Danub."},{"issue":"6","key":"10.1016\/j.jpsychores.2020.109975_bb0220","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/psyp.12634","article-title":"Sympathetic and hypothalamic-pituitary-adrenal asymmetry in generalized anxiety disorder","volume":"53","author":"Reeves","year":"2016","journal-title":"Psychophysiology."},{"key":"10.1016\/j.jpsychores.2020.109975_bb0225","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.psyneuen.2017.06.005","article-title":"Cortisol stress response in post-traumatic stress disorder, panic disorder, and major depressive disorder patients","volume":"83","author":"Wichmann","year":"2017","journal-title":"Psychoneuroendocrinology."},{"key":"10.1016\/j.jpsychores.2020.109975_bb0230","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.psyneuen.2016.11.036","article-title":"Cortisol stress reactivity across psychiatric disorders: A systematic review and meta-analysis","volume":"77","author":"Zorn","year":"2017","journal-title":"Psychoneuroendocrinology."},{"issue":"10","key":"10.1016\/j.jpsychores.2020.109975_bb0235","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/BF01273312","article-title":"Effects of interferon-gamma, interleukin-1 beta, and tumor necrosis factor-alpha on the serotonin metabolism in the nucleus raphe dorsalis of the rat","volume":"104","author":"Clement","year":"1997","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"1\u20132","key":"10.1016\/j.jpsychores.2020.109975_bb0240","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0006-8993(94)90006-X","article-title":"Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6","volume":"643","author":"Zalcman","year":"1994","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.jpsychores.2020.109975_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2008.01.004","article-title":"Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders","volume":"85","author":"Anisman","year":"2008","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/j.jpsychores.2020.109975_bb0250","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbi.2008.08.006","article-title":"Mechanisms of cytokine-induced behavioral changes: Psychoneuroimmunology at the translational interface","volume":"23","author":"Miller","year":"2009","journal-title":"Brain Behav. Immun"},{"key":"10.1016\/j.jpsychores.2020.109975_bb0255","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1477-7525-11-37","article-title":"Screening for anxiety disorders in patients with coronary artery disease","volume":"11","author":"Bunevicius","year":"2013","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.jpsychores.2020.109975_bb0260","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13643-015-0026-2","article-title":"Panic disorder and incident coronary heart disease: A systematic review and meta-analysis protocol","volume":"4","author":"Tully","year":"2015","journal-title":"Syst. Rev."},{"key":"10.1016\/j.jpsychores.2020.109975_bb0265","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jad.2015.09.040","article-title":"Association of asthma and anxiety: A nationwide population-based study in Taiwan","volume":"189","author":"Lee","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychores.2020.109975_bb0270","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neulet.2017.07.021","article-title":"The pro-inflammatory cytokines, salivary cortisol and alpha-amylase are associated with generalized anxiety disorder (GAD) in patients with asthma","volume":"656","author":"Yang","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jpsychores.2020.109975_bb0275","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jad.2019.04.037","article-title":"Allergic rhinitis increases the risk of incident panic disorder among young individuals: A nationwide population-based cohort study in Taiwan","volume":"252","author":"Hsieh","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychores.2020.109975_bb0280","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jpsychores.2019.01.007","article-title":"Relationship between major depressive disorder, generalized anxiety disorder and coronary artery disease in the US general population","volume":"119","author":"Liu","year":"2019","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.jpsychores.2020.109975_bb0285","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jad.2016.07.027","article-title":"Association of childhood trauma and panic symptom severity in panic disorder: Exploring the mediating role of alexithymia","volume":"206","author":"Zou","year":"2016","journal-title":"J. Affect. Disord."},{"issue":"1\u20133","key":"10.1016\/j.jpsychores.2020.109975_bb0290","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jad.2011.05.029","article-title":"Impact of stressful life events on the course of panic disorder in adults","volume":"134","author":"Moitra","year":"2011","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.jpsychores.2020.109975_bb0295","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jpsychores.2012.04.012","article-title":"Decreased IFN-gamma and IL-12 levels in panic disorder","volume":"73","author":"Tukel","year":"2012","journal-title":"J. Psychosom. Res."},{"issue":"12","key":"10.1016\/j.jpsychores.2020.109975_bb0300","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/npp.2011.132","article-title":"The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: A meta-analysis","volume":"36","author":"Hannestad","year":"2011","journal-title":"Neuropsychopharmacology."},{"issue":"10","key":"10.1016\/j.jpsychores.2020.109975_bb0305","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1017\/S0033291712000128","article-title":"Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: A meta-analysis","volume":"42","author":"Hiles","year":"2012","journal-title":"Psychol. Med."},{"issue":"12","key":"10.1016\/j.jpsychores.2020.109975_bb0310","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/jcph.963","article-title":"Effect of agomelatine and fluoxetine on HAM-D score, serum brain-derived neurotrophic factor, and tumor necrosis factor-alpha level in patients with major depressive disorder with severe depression","volume":"57","author":"Gupta","year":"2017","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jpsychores.2020.109975_bb0315","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.psyneuen.2017.10.009","article-title":"Differences in immunomodulatory properties between venlafaxine and paroxetine in patients with major depressive disorder","volume":"87","author":"Chen","year":"2018","journal-title":"Psychoneuroendocrinology."},{"key":"10.1016\/j.jpsychores.2020.109975_bb0320","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbi.2019.06.001","article-title":"Effects of SSRIs on peripheral inflammatory cytokines in patients with generalized anxiety disorder","volume":"81","author":"Hou","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.jpsychores.2020.109975_bb0325","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5498\/wjp.v6.i3.283","article-title":"Neuroinflammation and cytokine abnormality in major depression: Cause or consequence in that illness?","volume":"6","author":"Jeon","year":"2016","journal-title":"World J. Psychiatry."},{"key":"10.1016\/j.jpsychores.2020.109975_bb0330","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.comppsych.2019.152140","article-title":"Pre-treatment peripheral biomarkers associated with treatment response in panic symptoms in patients with major depressive disorder and panic disorder: A 12-week follow-up study","volume":"95","author":"Kim","year":"2019","journal-title":"Compr. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.jpsychores.2020.109975_bb0335","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.brainresrev.2011.01.002","article-title":"Interleukin-6, a mental cytokine","volume":"67","author":"Spooren","year":"2011","journal-title":"Brain Res. Rev."},{"issue":"2","key":"10.1016\/j.jpsychores.2020.109975_bb0340","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.intimp.2003.11.006","article-title":"Stimulatory effect of antidepressants on the production of IL-6","volume":"4","author":"Kubera","year":"2004","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.jpsychores.2020.109975_bb0345","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/JCP.0000000000001014","article-title":"Effects of cytochrome P450 2C19 genetic polymorphisms on responses to escitalopram and levels of brain-derived neurotrophic factor in patients with panic disorder","volume":"39","author":"He","year":"2019","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychores.2020.109975_bb0350","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neulet.2016.12.071","article-title":"DNA methylation and clinical response to antidepressant medication in major depressive disorder: A review and recommendations","volume":"669","author":"Lisoway","year":"2018","journal-title":"Neurosci. Lett."}],"container-title":["Journal of Psychosomatic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022399919309171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022399919309171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:44:37Z","timestamp":1758368677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022399919309171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":70,"alternative-id":["S0022399919309171"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychores.2020.109975","relation":{},"ISSN":["0022-3999"],"issn-type":[{"value":"0022-3999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in cytokines between patients with generalised anxiety disorder and panic disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychosomatic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychores.2020.109975","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109975"}}